Sequel Pharmaceuticals, Inc
Sequel Pharma LLC. is a privately held, specialty pharmaceutical company that acquires, develops, and markets products in select therapeutic areas, with a mission to improve the lives of patients by commercializing specialty pharmaceutical products.
Industries
Nr. of Employees
small (1-50)
Sequel Pharmaceuticals, Inc
300 Interpace Parkway, The Grand 1, Building C3, Parsippany, NJ 07054, United States
Products
Metoprolol succinate extended-release — U.S. marketing rights (divested)
Reference to a U.S. marketing rights transfer for an extended-release metoprolol succinate product; the company directed medical and safety inquiries to the acquiring commercial partner.
Metoprolol succinate extended-release — U.S. marketing rights (divested)
Reference to a U.S. marketing rights transfer for an extended-release metoprolol succinate product; the company directed medical and safety inquiries to the acquiring commercial partner.
Services
Transaction services to acquire or license marketing rights and product assets for inclusion in a specialty pharmaceutical portfolio.
Development management for specialty pharmaceutical assets, including formulation and progression through development milestones.
Commercial launch and marketing activities for specialty pharmaceutical products in selected therapeutic areas.
Transaction services to acquire or license marketing rights and product assets for inclusion in a specialty pharmaceutical portfolio.
Development management for specialty pharmaceutical assets, including formulation and progression through development milestones.
Commercial launch and marketing activities for specialty pharmaceutical products in selected therapeutic areas.
Expertise Areas
- Specialty pharmaceutical commercialization
- Product acquisition and licensing
- Pharmaceutical product development
- Regulatory compliance and submissions
Key Technologies
- Pharmaceutical formulation and product development
- Drug delivery technologies
- Regulatory submission processes (NDA/marketing applications)
- Product lifecycle and portfolio management